Xiaojun Pan Selected Research

Xiaojun Pan Research Topics

7	Sepsis (Septicemia) 12/2023 - 01/2016
4	Lung Injury 11/2020 - 01/2016
3	Inflammation (Inflammations) 11/2020 - 01/2018
2	Infections 11/2023 - 04/2023
2	Critical Illness (Critically Ill) 02/2023 - 08/2022
1	Myocardial Infarction 01/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Hypoglycemia (Reactive Hypoglycemia) 11/2023
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Hyperglycemia 11/2023
1	COVID-19 04/2023
1	Bacteremia 08/2022
1	Septic Shock (Toxic Shock Syndrome) 08/2022
1	Ventilator-Associated Pneumonia 08/2022

2	LipopolysaccharidesIBA 09/2022 - 11/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2024
1	ThymopentinIBA 12/2023
1	CytokinesIBA 12/2023
1	SaccharinIBA 12/2023
1	Blood Glucose (Blood Sugar)IBA 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	nirmatrelvir and ritonavir drug combinationIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 04/2023
1	Ritonavir (Norvir)FDA Link 04/2023
1	nirmatrelvirIBA 04/2023
1	cisatracurium (Nimbex)FDA Link 02/2023
1	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2022
1	ORALIT (ORS)IBA 08/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	Therapeutic UsesIBA 11/2020
1	napabucasinIBA 01/2020
1	antithrombin III-protease complexIBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	BP-1-102IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2016

5	Ligation 12/2023 - 01/2016
4	Punctures 11/2020 - 01/2016
2	Therapeutics 08/2022 - 01/2018
1	Critical Care (Surgical Intensive Care) 02/2023